Document Detail


Primary endocrinomas (carcinoids and variant neoplasms) of the gallbladder. A statistical evaluation of 138 reported cases.
MedLine Citation:
PMID:  12725316     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study was carried out to obtain extensive information on carcinoids (the carcinoid group) and related variant endocrinomas (the variant group) of the gallbladder, and to statistically analyze their characteristics from various clinicopathologic aspects. A total of 138 cases were collected from the international sources, 101 belonging to the carcinoid group and 37 to the variant group. The first group consisted of 81 cases of typical and 20 atypical carcinoids. Comparative evaluation was attempted mainly between the carcinoid and variant groups, and occasionally between the typical and atypical carcinoid series when statistical significance was suspected. The carcinoid group showed a statistically significant difference from the variant group by exhibiting a younger average age (61.7 years vs 69.7 years: P<0.01), a higher incidence of associated cholelithiasis (87.3% vs 56.0%: P<0.01), a higher incidence of small tumors 50 mm or less (85.2% vs 52.9%: P<0.01), a smaller average tumor-size (29.6 mm vs 58.7 mm: P<0.01), a lower rate of metastases (40.7% vs 70.6%: P<0.05), a higher immunoreactivity rate of chromogranin (100.0% vs 66.7%: P<0.01), a lower immunoreactivity rate of gastrin (23.8% vs 70.6%: P<0.01), and a higher five-year survival rate (60.4% vs 21.3%: P<0.0005). Significant differences in various clinicopathological aspects confirmed between the carcinoid group and the variant group suggested that endocrine carcinomas of these two groups perform a different clinical pattern, represented most clearly by postoperative outcomes. These groupings are decided on the basis of histologic patterns, namely, well to poorly differentiated endocrine carcinomas (typical to atypical carcinoids) and undifferentiated or anaplastic variants of other endocrine carcinomas. The basic criteria for such classification of these endocrine carcinomas based on international agreements are required.
Authors:
J Soga
Related Documents :
15771616 - The ret proto-oncogene: a molecular therapeutic target in thyroid cancer.
6127216 - Familial medullary thyroid carcinoma in multiple endocrine neoplasia (men) iia: diagnos...
2164716 - Unusual lesions and their management.
17167516 - Cancer phenomics: ret and pten as illustrative models.
24810296 - Verrucous carcinoma of the foot, not your typical plantar wart: a case study.
7693336 - Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of experimental & clinical cancer research : CR     Volume:  22     ISSN:  0392-9078     ISO Abbreviation:  J. Exp. Clin. Cancer Res.     Publication Date:  2003 Mar 
Date Detail:
Created Date:  2003-05-02     Completed Date:  2004-01-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8308647     Medline TA:  J Exp Clin Cancer Res     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  5-15     Citation Subset:  IM    
Affiliation:
The Niigata Seiryo University, Niigata City, Niigata, Japan. soga@n-seiryo.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Age Factors
Aged
Bone Neoplasms / pathology,  secondary
Carcinoid Tumor / mortality,  pathology*
Female
Gallbladder Neoplasms / mortality,  pathology*
Humans
Liver Neoplasms / pathology,  secondary
Lung Neoplasms / pathology,  secondary
Lymphatic Metastasis
Male
Middle Aged
Multiple Endocrine Neoplasia / mortality,  pathology
Pancreatic Neoplasms / pathology,  secondary
Peritoneal Neoplasms / pathology,  secondary
Retrospective Studies
Survival Analysis
Time Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of cattle for experimental infection with and transmission of Brucella suis biovar 4.
Next Document:  Prevention of radiotherapy-induced emesis.